Skip to main content

Advertisement

Fig. 4 | Cancer Imaging

Fig. 4

From: Hepatocellular carcinoma: radiomics nomogram on gadoxetic acid-enhanced MR imaging for early postoperative recurrence prediction

Fig. 4

Decision curve analysis for each model. The y-axis measures the net benefit, and the x-axis is the threshold probability. Using the radiomics nomogram for early recurrence prediction has more benefit than either the treat-all-patients scheme (gray line) or the treat-none scheme (horizontal black line). The radiomics nomogram (green line) received a higher net benefit than either the clinical-radiological nomogram or the radiomics score alone across the full range of reasonable threshold probabilities

Back to article page